Usual opioid dosing does not adversely affect the course of healthcare-associated Clostridioides difficile infection

Pain Manag. 2021 Mar;11(2):151-157. doi: 10.2217/pmt-2020-0066. Epub 2020 Dec 22.

Abstract

Aim: We sought to determine if opioid exposure may have a detrimental effect on the course of Clostridioides difficile infection (CDI). Materials & methods: We compared opioid exposure in patients with well-defined severe CDI and non-severe CDI. Results: Following exclusions, 403 records were reviewed. Of this group, 128/403 (31.7%) were determined to have severe CDI by strict criteria, and 275/403 (68.3%) were found to have non-severe CDI. Full multivariate regression and reduced model of potential predictors for severe CDI showed no association with opioids prescribed. Conclusion: Opioid exposure (predominantly in modest range) does not appear to be a risk factor for severe healthcare-associated CDI.

Keywords: Clostridium difficile infection; healthcare-associated infections; nosocomial infections; opioids; pain management; severe Clostridioides difficile infection.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Analgesics, Opioid / administration & dosage*
  • Analgesics, Opioid / adverse effects*
  • Clostridium Infections / etiology*
  • Cross Infection / etiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pain Management*
  • Process Assessment, Health Care*
  • Retrospective Studies
  • Severity of Illness Index

Substances

  • Analgesics, Opioid